Caliper Life investors buy, sell shares for 6.1% ownership interest

By Lisa Kerner

Charlotte, N.C., June 17 - A group of Caliper Life Sciences, Inc. shareholders led by Integrated Core Strategies (US) LLC beneficially own 3,014,733 shares of the company's stock following a series of buy and sell transactions between April 16 and June 15, according to a schedule 13D/A filed on Wednesday with the Securities and Exchange Commission.

The investors have a 6.1% stake in the Hopkinton, Mass.-based company.

Caliper Life Sciences develops and markets life science instruments for the pharmaceutical and biotechnology industries.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.